Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Siemens sets up research laboratories for molecular diagnostics in Germany

Siemens Healthcare Deutschland : 04 June, 2008  (Company News)
Siemens Healthcare has established new research laboratories for molecular diagnostics in Cologne, Germany that will focus research efforts on ‘breast cancer’, a disease that remains the number one cause of death among young women despite the large number of therapies currently available.
Almost 40 Siemens employees have been developing new diagnostic tests to help the treating physician find an individually optimised therapy for as many patients as possible, thus combining better chances of recovery than are now offered by today's medical state-of-the-art technology, with reduced side effects. In addition, Siemens has been researching innovative biochips to enable clinics to perform the newly developed breast cancer tests.

The problem with treating breast cancer: Until now, it has not been possible to predict the individual effectiveness of the various breast cancer therapies currently available. It therefore cannot be ensured that each patient will receive the therapy that is optimal for her. In order to improve this situation, 40 Siemens employees in Cologne have been developing innovative diagnostic tests which can be used to precisely describe the molecular characteristics of a patient's tumour cells. The results should help the treating physician adapt the therapy to the individual patient.

In addition, Siemens has been researching innovative biochips at its Cologne laboratory with which the newly developed breast cancer tests can be performed. Biochips can perform hundreds, and in extreme cases hundreds of thousands, of diagnostic tests simultaneously. Many different tumour characteristics must be investigated in order to identify the possible of various therapies. Biochips are therefore especially suitable for performing a high number of required tests both fast and efficiently.

'Siemens Healthcare chose Cologne as the new site for its molecular diagnostics research in Germany because this city is one of Europe's leading competence centres in the field of biomedicine', said Donal Quinn, chief executive officer of the Diagnostics Division of Siemens Healthcare. 'Viewed from the perspective of Siemens, a medicine that is more strongly based on molecular medical and knowledge-based techniques will be able to make important long-term contributions toward improving the quality and increasing the efficiency of healthcare.'

Breast cancer causes death among women, more often than any other cancer. Over 150,000 women are treated for breast cancer in Germany every year. More than 17,000 of them die from this disease annually. For this reason, not only quality-tested early detection of breast cancer, but also individual therapies ensured by reliable diagnostics are important. Siemens Healthcare has therefore developed comprehensive solutions for the early detection and treatment of breast cancer under the name ‘Breast Care Solutions’. These solutions comprise a combination of different imaging techniques including ultrasound, mammography and magnetic resonance imaging, which are now supplemented by innovative laboratory diagnostic tests and DP based evaluation systems.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   Â© 2012 ProHealthServiceZone.com
Netgains Logo